Phenobarbital

ADVERTISEMENT

Identification

Molecular formula
C12H12N2O3
CAS Number
50-06-6
IUPAC Name
3-ethyl-5-phenyl-imidazolidine-2,4-dione
Molecular Weight
232.24g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.1000g/cm3
Synonyms
ethotoin
Interesting facts

Interesting Facts about 3-Ethyl-5-phenyl-imidazolidine-2,4-dione

3-Ethyl-5-phenyl-imidazolidine-2,4-dione, also known as an important derivative in the realm of heterocyclic compounds, has a variety of intriguing applications and properties that make it a point of interest in both organic chemistry and pharmaceuticals.

1. Structure and Functionality

  • The compound contains a unique imidazolidine ring, characterized by its five-membered structure that includes nitrogen atoms.
  • It features both ethyl and phenyl substituents, which can influence the compound's reactivity and solubility profiles.

2. Pharmaceutical Relevance

This compound is significant in medicinal chemistry due to its potential applications in drug development. Some highlights include:

  • Possibility of serving as a precursor in synthesizing novel drug molecules.
  • Potential activity as an anti-inflammatory agent, making it of interest for treating various health conditions.

3. Synthetic Pathways

The synthesis of 3-ethyl-5-phenyl-imidazolidine-2,4-dione can involve several strategies, often focusing on:

  • Condensation reactions that build the imidazolidine framework.
  • Functional group modifications that allow for diverse derivatives to be formed, broadening the applications of this compound.

4. Quote from Experts

As noted by many chemists, “Understanding the derivatives of compounds like 3-ethyl-5-phenyl-imidazolidine-2,4-dione opens new avenues in the pharmaceutical sector.” This highlights the importance of exploring related structures for innovative solutions.

This compound serves as a fascinating example of the intersection of structural chemistry and medicinal applications, illustrating how small variations in chemical structure can lead to significant differences in biological activity and therapeutic potential.

ADVERTISEMENT